bigvision

When it comes to the rising stars in the AI industry, ChatGPT is unrivaled. It took Instagram two and a half years (30 months) to reach 100 million users, while TikTok took nine months. However, just two months after its launch, ChatGPT’s monthly active users exceeded 100 million at the end of January 2023, making it the fastest-growing consumer application in history. Microsoft co-founder Bill Gates said in an interview that the importance of ChatGPT is no less than the

Gao Tai County is located in the middle of the Hexi Corridor in Gansu Province, downstream of the Heihe River. It has been known as the “key to the Hexi Corridor and the throat of five prefectures” since ancient times. During the Han Dynasty, it was an essential stop on the Silk Road, with national key cultural relics protection units such as the Camel City ruins, Xu San Wan city and tombs group, and the Han Ming Great Wall located

Bachu is located at the southern foothills of Tianshan Mountains, on the northwest edge of the Tarim Basin and the Taklamakan Desert. It is known as the “eastern gateway” to Kashgar Prefecture in Xinjiang. In history, Bachu was an important post station on the Silk Road, and it is home to the ancient city of Qiuci and beacon tower ruins from the Tang Dynasty. These relics are considered a “museum” and “living fossil” of the Silk Road. The ancient city of

On January 13th, 2023, a delegation led by Professor Qu Jia, Chairman of the Chinese Eye Valley Council, Director of the International Innovation Center, and General Hospital Director of the Wenzhou Medical University Eye Hospital Group; Professor Lv Fan, Director of the National Clinical Medical Research Center and Chief Scientist of the Chinese Eye Valley; and Dr. Xu Liangde, Secretary-General of the Chinese Eye Valley Council and Executive Director of the International Innovation Center, visited Big Vision Medical to conduct

The year 2022 that has just passed has been an extraordinary year; the recurrence of the epidemic has brought huge challenges to companies’ market development and other work. For medical AI, including ophthalmic AI, 2022 is another year of great significance. At the beginning of the year, artificial intelligence was included in the “14th Five-Year Plan” National Eye Health Plan for the first time: In September, Shenzhen and Shanghai successively released Regulations on promoting the development of the artificial intelligence

On December 6, 2022, the latest model of the self-developed ophthalmic optical coherence tomography (OCT) scanner by Big Vision Medical Technology, BV1000S, was successfully registered, becoming the newest member of Big Vision’s fully automatic artificial intelligence OCT product line. Product advantages Optical coherence tomography (OCT) is an important ophthalmic diagnostic tool that uses high-resolution and non-invasive imaging to visualize the microstructure of the retina, completely changing the way ophthalmic patients are examined and diagnosed, and has been widely used in ophthalmic clinics. Since the

On December 24, 2022, the satellite session of Big Vision at the 23rd Chinese Retinal Disease Forum and International Retina Symposium was successfully held online. The conference invited Professor Xu Xun from Shanghai First People’s Hospital, Professor Wei Wenbin from Beijing Tongren Hospital, and Professor Song Zongming from Henan Provincial Eye Hospital as keynote speakers to share the application and prospects of AI OCT in the diagnosis and treatment of retinal diseases and systemic chronic disease management. The conference invited Professor

Recently, the Big Vision Satellite Symposium was successfully held online at the 26th National Ophthalmology Congress of Chinese Medical Association. The conference invited Professor Xu Xun from Shanghai First People’s Hospital, Professor Lv Fan from Wenzhou Medical University Affiliated Eye Center, and Professor Tang Shibo from Aier Eye Hospital Group as keynote speakers to share their wonderful insights on the clinical application and practice of AI OCT. Satellite Symposium Review Under the joint leadership of Professor Chen Haoyu from Joint Shantou International Eye

On November 26, 2022, the Second Suzhou International Forum on Ophthalmic Artificial Intelligence was held in Suzhou. The conference was jointly organized by the Medical Image Processing and Analysis Laboratory of Suzhou University, the National Clinical Research Center for Eye Diseases, and the China Life Science and Technology Industry Alliance. It was hosted by Suzhou Big Vision Medical Technology Co., Ltd. and co-organized by the Oriental Medical Device Industry Technology Innovation Center. The conference invited many well-known scholars in the field of

Recently, Big Vision, in collaboration with ophthalmology experts Director Peng Qing and Director Gao Peng from the Shanghai Tenth People’s Hospital, published a paper in the renowned journal Frontiers in Cell and Development Biology (impact factor: 6.081). This study verified the feasibility and effectiveness of Big Vision’s ophthalmic AI in community eye disease screening. Age-related macular degeneration (AMD), diabetic retinopathy (DR), high myopia, as well as macular diseases such as macular epiretinal membrane and macular hole are important factors causing vision